Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema

Figure 2

Changes of the mean CMT before and after IVA and IVR treatment in eyes with or without a SRD. The CMT thickness is still significantly reduced 6 months after both IVA and IVR. Data are expressed as mean ± SEM. ; relative to the baseline of the CMT. CMT, central macular thickness; SRD, serous retinal detachment; IVR, intravitreal ranibizumab injection; IVA, intravitreal aflibercept injection.